D. E. Shaw & Co., Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
4,410
Total Value
56236260077
Accession Number
0001104659-25-049422
Form Type
13F-HR
Manager Name
D. E. Shaw & Co., Inc.
Data Enrichment
86% identified
3,801 identified609 unidentified

Holdings

4,410 positions
Manager:
Search and click to pin securities to the top
Page 130 of 157
Warby Parker Inc.
Shares:
22700(-98.7%)
Value:
$413.8M(-99.0%)
GORMAN RUPP CO
Shares:
11760
Value:
$412.8M
CBL & ASSOCIATES PROPERTIES INC
Shares:
15488(-40.9%)
Value:
$411.7M(-46.6%)
14021L109
Shares:
13297
Value:
$410.9M
69374H873
Shares:
13025(-6.5%)
Value:
$409.1M(+0.8%)
SIMMONS FIRST NATIONAL CORP
Shares:
19877
Value:
$408.1M
IDACORP INC
Shares:
3497(+79.2%)
Value:
$406.4M(+90.6%)
Ryerson Holding Corp
Shares:
17654(-54.0%)
Value:
$405.3M(-43.0%)
SAUL CENTERS, INC.
Shares:
11168(+57.0%)
Value:
$402.8M(+46.0%)
Safehold Inc.
Shares:
21500(+104.6%)
Value:
$402.5M(+107.2%)
922908652
Shares:
2335
Value:
$402.2M
HEICO CORP
Shares:
1500(-42.3%)
Value:
$400.8M(-35.2%)
500767405
Shares:
16934(-31.6%)
Value:
$400.0M(-31.1%)
Qifu Technology, Inc.
Shares:
8900(+34.8%)
Value:
$399.7M(+57.8%)
Valaris Ltd
Shares:
10153(-52.3%)
Value:
$398.6M(-57.7%)
Apellis Pharmaceuticals, Inc.
Shares:
18200(-42.6%)
Value:
$398.0M(-60.6%)
Montauk Renewables, Inc.
Shares:
190352(-12.3%)
Value:
$397.8M(-53.9%)
Esperion Therapeutics, Inc.
Shares:
275707(+9.6%)
Value:
$397.0M(-28.3%)
46138E586
Shares:
3178(+0.0%)
Value:
$395.9M(+7.3%)
25434V658
Shares:
15059(+23.4%)
Value:
$395.4M(+26.9%)